Positron (POSC) vs. Its Competitors Head to Head Analysis

Profitability This table compares Positron and its peers’ net margins, return on equity and return on assets. Risk and Volatility Positron has a beta of 0.48, suggesting that its stock price is 52% less volatile than the S&P 500.

Comparatively, Positron’s peers have a beta of 0.92, suggesting that their average stock price is 8% less volatile than the S&P 500. Institutional and Insider Ownership 44.



3% of shares of all “Electromedical equipment” companies are owned by institutional investors. 17.2% of Positron shares are owned by insiders.

Comparatively, 15.1% of shares of all “Electromedical equipment” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Earnings and Valuation Positron’s peers have higher revenue and earnings than Positron. Positron is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry. Summary Positron peers beat Positron on 7 of the 9 factors compared.

Positron Company Profile ( Get Free Report ) Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.

Receive News & Ratings for Positron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Positron and related companies with MarketBeat.com's FREE daily email newsletter ..